Binding of disordered proteins to a protein hub

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Cino, Elio A ^a   Killoran, Ryan C ^a   Karttunen, Mikko ^b   Choy, Wing Yiu ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF WATERLOO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INTRINSICALLY DISORDERED PROTEIN; PEPTIDE;

AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; METABOLISM; MOLECULAR GENETICS; POSITION WEIGHT MATRIX; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN MOTIF; SEQUENCE ALIGNMENT; THERMODYNAMICS;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; BINDING SITES; INTRINSICALLY DISORDERED PROTEINS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDES; POSITION-SPECIFIC SCORING MATRICES; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; SEQUENCE ALIGNMENT; THERMODYNAMICS;

EID: 84881127333     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep02305     Document Type: Article

References (63)

1. Rual, J. F. et al. Towards a proteome-scale map of the human protein-protein interaction network. Nature 437, 1173-1178 (2005).
2. Stelzl, U. et al. A human protein-protein interaction network: a resource for annotating the proteome. Cell 122, 957-968 (2005). (Pubitemid 41345212)
3. Ekman, D., Light, S., Bjorklund, A. K. & Elofsson, A. What properties characterize the hub proteins of the protein-protein interaction network of Saccharomyces cerevisiae? Genome Biol 7, R45 (2006).
4. Han, J. D. et al. Evidence for dynamically organized modularity in the yeast protein-protein interaction network. Nature 430, 88-93 (2004).
5. Vidal, M., Cusick, M. E. & Barabasi, A. L. Interactome networks and human disease. Cell 144, 986-998 (2011).
6. Dunker, A. K., Cortese, M. S., Romero, P., Iakoucheva, L. M. & Uversky, V. N. Flexible nets. The roles of intrinsic disorder in protein interaction networks. FEBS J 272, 5129-5148 (2005). (Pubitemid 41503146)
7. Das, R. K., Mao, A. H. & Pappu, R. V. Unmasking functional motifs within disordered regions of proteins. Sci Signal 5, pe17 (2012).
8. Davey, N. E. et al. Attributes of short linear motifs. Mol Biosyst 8, 268-281 (2012).
9. Mészáros, B., Tompa, P., Simon, I. & Dosztányi, Z. Molecular principles of the interactions of disordered proteins. J Mol Biol 372, 549-561 (2007). (Pubitemid 47267965)
10. Cino, E. A., Choy, W.-Y. & Karttunen, M. Comparison of Secondary Structure Formation Using 10 Different Force Fields in Microsecond Molecular Dynamics Simulations. J Chem Theory Comput 8, 2725-2740 (2012).
11. Cino, E. A., Wong-Ekkabut, J., Karttunen, M. & Choy, W. Y. Microsecond molecular dynamics simulations of intrinsically disordered proteins involved in the oxidative stress response. PLoS One 6, e27371 (2011).
12. Fuxreiter, M., Simon, I., Friedrich, P. & Tompa, P. Preformed structural elements feature in partner recognition by intrinsically unstructured proteins. J Mol Biol 338, 1015-1026 (2004). (Pubitemid 38542830)
13. Mohan, A. et al. Analysis of molecular recognition features (MoRFs). J Mol Biol 362, 1043-1059 (2006). (Pubitemid 44353519)
14. Itoh, K. et al. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev 13, 76-86 (1999). (Pubitemid 29045117)
15. Tong, K. I. et al. Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model. Mol Cell Biol 26, 2887-2900 (2006).
16. Tong, K. I., Kobayashi, A., Katsuoka, F. & Yamamoto, M. Two-site substrate recognition model for the Keap1-Nrf2 system: a hinge and latch mechanism. Biol Chem 387, 1311-1320 (2006). (Pubitemid 44691409)
17. Camp, N. D. et al. Wilms Tumor Gene on X Chromosome (WTX) Inhibits Degradation of NRF2 Protein through Competitive Binding to KEAP1 Protein. J Biol Chem 287, 6539-6550 (2012).
18. Komatsu, M. et al. The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat Cell Biol 12, 213-223 (2010).
19. Lo, S.-C. & Hannink, M. PGAM5, a Bcl-XL-interacting protein, is a novel substrate for the redox-regulated Keap1-dependent ubiquitin ligase complex. J Biol Chem 281, 37893-903 (2006). (Pubitemid 46042093)
20. Ma, J. et al. PALB2 interacts with KEAP1 to promote NRF2 nuclear accumulation and function. Mol Cell Biol 32, 1506-1517 (2012).
21. Strachan, G. D. et al. Fetal Alz-50 clone 1 interacts with the human orthologue of the Kelch-like Ech-associated protein. Biochemistry 43, 12113-12122 (2004). (Pubitemid 39280555)
22. Padmanabhan, B., Nakamura, Y. & Yokoyama, S. Structural analysis of the complex of Keap1 with a prothymosin alpha peptide. Acta Crystallogr Sect F Struct Biol Cryst Commun 64, 233-238 (2008). (Pubitemid 351507811)
23. Kim, J.-E. et al. Suppression of NF-kappaB signaling by KEAP1 regulation of IKKbeta activity through autophagic degradation and inhibition of phosphorylation. Cell Signal 22, 1645-1654 (2010).
24. Niture, S. K. & Jaiswal, A. K. INrf2 (Keap1) targets Bcl-2 degradation and controls cellular apoptosis. Cell Death Differ 18, 439-451 (2011).
25. Velichkova, M. et al. A human homologue of Drosophila kelch associates with myosin-VIIa in specialized adhesion junctions. Cell Motil Cytoskeleton 51, 147-164 (2002). (Pubitemid 34246089)
26. Yi, S., Boys, B. L., Brickenden, A., Konermann, L. & Choy, W. Y. Effects of zinc binding on the structure and dynamics of the intrinsically disordered protein prothymosin alpha: evidence for metalation as an entropic switch. Biochemistry 46, 13120-13130 (2007). (Pubitemid 350089907)
27. Xue, B., Dunbrack, R. L., Williams, R. W., Dunker, A. K. & Uversky, V. N. PONDR-FIT: a meta-predictor of intrinsically disordered amino acids. Biochim Biophys Acta 1804, 996-1010 (2010).
28. Kalia, M. & Kukol, A. Structure and dynamics of the kinase IKK-b - A key regulator of the NF-kappa B transcription factor. J Struct Biol 176, 133-142 (2011).
29. Petros, A. M. et al. Solution structure of the antiapoptotic protein bcl-2. Proc Natl Acad Sci U S A 98, 3012-3017 (2001). (Pubitemid 32220791)
30. Lo, S.-C., Li, X., Henzl, M. T., Beamer, L. J. & Hannink, M. Structure of the Keap1:Nrf2 interface provides mechanistic insight into Nrf2 signaling. EMBO J 25, 3605-3617 (2006). (Pubitemid 44264871)
31. Padmanabhan, B. et al. Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer. Mol Cell 21, 689-700 (2006). (Pubitemid 43290735)
32. Tong, K. I. et al. Different electrostatic potentials define ETGE and DLGmotifs as hinge and latch in oxidative stress response. Mol Cell Biol 27, 7511-7521 (2007). (Pubitemid 350033657)
33. Andersson, M., Ulmschneider, J. P., Ulmschneider, M. B. & White, S. H. Conformational states of melittin at a bilayer interface. Biophys J 104, L12-14 (2013).
34. Mittal, J., Yoo, T. H., Georgiou, G. & Truskett, T. M. Structural ensemble of an intrinsically disordered polypeptide. J Phys Chem B 117, 118-124 (2013).
35. Kyte, J. & Doolittle, R. F. A simple method for displaying the hydropathic character of a protein. J Mol Biol 157, 105-132 (1982).
36. Hancock, R. et al. Peptide inhibitors of the Keap1-Nrf2 protein-protein interaction. Free Radic Biol Med 52, 444-451 (2012).
37. Itoh, K. et al. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun 236, 313-322 (1997). (Pubitemid 27373291)
38. Niture, S. K. & Jaiswal, A. K. Prothymosin-alpha mediates nuclear import of the INrf2/Cul3 Rbx1 complex to degrade nuclear Nrf2. J Biol Chem 284, 13856-13868 (2009).
39. Stȩpkowski, T. M. & Kruszewski, M. K. Molecular cross-talk between the NRF2/KEAP1 signaling pathway, autophagy, and apoptosis. Free Radic Biol Med 50, 1186-1195 (2011).
40. Tian, H. et al. Keap1: One stone kills three birds Nrf2, IKKb and Bcl-2/Bcl-xL. Cancer Lett 325, 26-34 (2012).
41. Li, Y., Paonessa, J. D.&Zhang, Y. Mechanism of chemical activation of Nrf2. PLoS One 7, e35122 (2012).
42. Rojas-Rivera, J., Ortiz, A.&Egido, J. Antioxidants in kidney diseases: the impact of bardoxolone methyl. Int J Nephrol 2012, 321714 (2012).
43. Sporn, M. B. & Liby, K. T. NRF2 and cancer: the good, the bad and the importance of context. Nat Rev Cancer 12, 564-571 (2012).
44. Sporn, M. B. et al. New synthetic triterpenoids: potent agents for prevention and treatment of tissue injury caused by inflammatory and oxidative stress. J Nat Prod 74, 537-545 (2011).
45. Zhang, Y. & Gordon, G. B. A strategy for cancer prevention: stimulation of the Nrf2-ARE signaling pathway. Mol Cancer Ther 3, 885-893 (2004). (Pubitemid 39193771)
46. Brunger, A. T. Version 1.2 of the Crystallography and NMR system. Nat Protoc 2, 2728-2733 (2007).
47. Pettersen, E. F. et al. UCSF Chimera-a visualization system for exploratory research and analysis. J Comput Chem 25, 1605-1612 (2004).
48. Hess, B.,Kutzner,C., van der Spoel, D.&Lindahl, E.GROMACS4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. J Chem Theory Comput 4, 435-447 (2008).
49. Oostenbrink, C., Soares, T. A., van der Vegt, N. F. A. & van Gunsteren, W. F. Validation of the 53A6 GROMOS force field. Eur Biophys J 34, 273-284 (2005). (Pubitemid 40884072)
50. Oostenbrink, C., Villa, A., Mark, A. E. & van Gunsteren, W. F. A biomolecular force field based on the free enthalpy of hydration and solvation: The GROMOS force-field parameter sets 53A5 and 53A6. J Chem Theory Comput 25, 1656-1676 (2004).
51. Hansson, T., Nordlund, P. & Aqvist, J. Energetics of nucleophile activation in a protein tyrosine phosphatase. J Mol Biol 265, 118-127 (1997). (Pubitemid 27110651)
52. Berendsen, H. J. C., Postma, J. P. M. & Gusteren, W. F. Interaction models for water in relation to protein hydration. in Intermolecular forces 331-342 (1981).
53. Wong-Ekkabut, J. & Karttunen, M. Assessment of common simulation protocols for simulations of nanopores, membrane proteins and channels. J Chem Theory Comput 8, 2905-2911 (2012).
54. Wong-Ekkabut, J., Miettinen, M. S., Dias, C. & Karttunen, M. Static charges cannot drive a continuous flow of water molecules through a carbon nanotube. Nat Nanotechnol 5, 555-557 (2010).
55. Bussi, G., Donadio, D. & Parrinello, M. Canonical sampling through velocity rescaling. J Chem Phys 126, 014101 (2007).
56. Parrinello, M. & Rahman, A. Polymorphic transitions in single crystals: A new molecular dynamics method. J Appl Phys 52, 7182-7190 (1981). (Pubitemid 12456820)
57. Hess, B., Bekker, H., Berendsen, H. J. C. & Johannes, J. G. E. M. A linear constraint solver for molecular simulations. J Comput Chem 18, 1463-1472 (1997). (Pubitemid 127637344)
58. Darden, T., York, D.&Pedersen, L. Particle mesh Ewald: AnN?log(N)method for Ewald sums in large systems. J Chem Phys 98, 10089-10093 (1993).
59. MacArthur, M. W. & Thornton, J. M. Conformational analysis of protein structures derived from NMR data. Proteins 17, 232-251 (1993). (Pubitemid 23331455)
60. Crooks, G. E., Hon, G., Chandonia, J.-M. & Brenner, S. E. WebLogo: a sequence logo generator. Genome Res 14, 1188-1190 (2004). (Pubitemid 38811555)
61. Larkin, M. A. et al. Clustal W and Clustal X version 2.0. Bioinformatics 23, 2947-2948 (2007). (Pubitemid 350162903)
62. Humphrey, W., Dalke, A. & Schulten, K. VMD: visual molecular dynamics. J Mol Graph 14, 33-38 (1996). (Pubitemid 26152973)
63. Zhao, J., Redell, J. B., Moore, A. N. & Dash, P. K. A novel strategy to activate cytoprotective genes in the injured brain. Biochem Biophys Res Commun 407, 501-506 (2011).